We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+21.54%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.08B
AUM Growth
+$375M
Cap. Flow
-$205M
Cap. Flow %
-3.37%
Top 10 Hldgs %
23.61%
Holding
263
New
25
Increased
137
Reduced
69
Closed
23

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$212M
2
BPMC
Blueprint Medicines
BPMC
+$93.4M
3
WDAY icon
Workday
WDAY
+$28M
4
RELY icon
Remitly
RELY
+$27M
5
INSM icon
Insmed
INSM
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.53%
2 Industrials 18.58%
3 Technology 17.54%
4 Consumer Discretionary 8.04%
5 Utilities 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTG icon
251
Entegris
ENTG
$19.1B
-12,376
Closed -$998K
EOG icon
252
EOG Resources
EOG
$77.6B
-3,448
Closed -$416K
FICO icon
253
Fair Isaac
FICO
$22.6B
-7,842
Closed -$14.3M
IT icon
254
Gartner
IT
$10.1B
-1,073
Closed -$432K
KD icon
255
Kyndryl
KD
$3.07B
-28,029
Closed -$1.18M
PCTY icon
256
Paylocity
PCTY
$7.48B
-6,411
Closed -$1.16M
PNFP icon
257
Pinnacle Financial Partners Inc
PNFP
$16.2B
-4,579
Closed -$502K
RELY icon
258
Remitly
RELY
$5.05B
-1,440,194
Closed -$27M
RLI icon
259
RLI Corp
RLI
$5.62B
-110,072
Closed -$7.95M
SNPS icon
260
Synopsys
SNPS
$75.1B
-2,207
Closed -$1.11M
W icon
261
Wayfair
W
$11.8B
-12,982
Closed -$665K
ALAB icon
262
Astera Labs
ALAB
$55B
-6,923
Closed -$626K

Similar funds

Eventide Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, Eventide Asset Management held 263 positions worth $6.08B, up 6.6% from $5.71B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management withdrew a net $205M in Q3 2025, closing 23 positions and reducing 69 holdings. Its most notable exit was Blueprint Medicines, an estimated $93.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in Soleno Therapeutics worth $31.6M.

  • Eventide Asset Management's largest Q3 2025 buy was Soleno Therapeutics: 467,435 shares worth $31.6M.
  • Eventide Asset Management added most to Talen Energy Corp in Q3 2025, an estimated $29.8M increase.
  • Eventide Asset Management's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $212M.
  • Eventide Asset Management fully exited Blueprint Medicines in Q3 2025, selling an estimated $93.4M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.08B portfolio in Q3 2025.
  • Eventide Asset Management opened 25 new positions and closed 23 in Q3 2025.
  • Eventide Asset Management's portfolio value rose 6.6% quarter-over-quarter to $6.08B.

Based on Eventide Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.